Added to YB: 2025-07-08
Pitch date: 2025-07-04
HVO.L [bullish]
hVIVO plc
Author Info
DeepValue Capital is investing in quality turnaround companies. Sign up for the newsletter.
Company Info
hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.
Market Cap
GBP 73.1M
Pitch Price
N/A
Price Target
43.55
Dividend
1.86%
Sector
Life Sciences Tools and Services
Category
value
hVIVO | The CRO Niche Leader Everyone’s Ignoring, and It’s a 4x Setup
HVO.L: Global leader in human challenge trials at ~70% off after guidance cut. £62.7M rev +12% YoY, 26.2% EBITDA margin. Controls 50%+ market share with proprietary viral strains and 170 beds. Two acquisitions expand capabilities. £44M cash, no dilution. 2028 target: £100M rev, £20M FCF. Risks: customer concentration, biotech funding. PT 43.55p (306% upside).
Read full article (7 min)